Clinical Trial Update: Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/Phase II trial of a recombinant human serum albumin/interferon alpha-2a fusion protein in chronic hepatitis B patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Recombinant Human Serum Albumin/Interferon alpha-2a Fusion Protein

Snippet

Sponsor: Beijing Bio-Fortune Ltd. | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED